Contravisory Investment Management, Inc. Novartis Ag Transaction History

Contravisory Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$80.52 - $93.75 $18,519 - $21,562	-230 Closed	0 $0
Q1 2022 Apr 08, 2022	BUY	$80.11 - $90.62 $18,425 - $20,842	230 New	230 $20,000
Q4 2019 Jan 09, 2020	SELL	$84.35 - $95.37 $47,995 - $54,265	-569 Closed	0 $0
Q3 2019 Oct 07, 2019	BUY	$85.54 - $94.26 $1,454 - $1,602	17 Added 3.08%	569 $49,000
Q2 2019 Jul 09, 2019	BUY	$75.4 - $92.8 $41,620 - $51,225	552 New	552 $50,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.